Guest guest Posted September 30, 2001 Report Share Posted September 30, 2001 WHAT WAS THE AMOUNT OF RAI (mci)YOU HAD FOR YOUR FIRST TREATMENT AFTER SURGERY? ~~m/r, 50 yof: 1996 dx: stage 2 pap/follic- 2 nodules less than 1 cm on left lobe. no mets. no lymph node involvement. treatment: total thyroidectomy w/vocal chords & all 4 parathyroids left intact. RAI 110 mCi 1997 clean scan It is my understanding that course of treatment is not 'one size fits all'. It sounds 'routine' - because the majority of cases of thyroid cancer fall under the 'papillary- no spread ' variety and the proven path of treatment is ninety- something percent successful. Then there are the rest of us who will have some little wrench thrown in- eg: age at dx or 2 different cancer cells present or lymph node involvement or larger nodules, ( remember there are different c. cells/types and several stages) etc etc Having read about or heard of dozens of stories over the course of my journey, from what the docs have said here and the course my own doctors took- IMHO, if I were your wife, I would opt for a TT. ...and to the person whose docs are considering the lowest dose of RAI- I have no idea if this is going to be the best route for you or not- I am only a happy survivor- but if they gave me a choice- I would prefer an hour or day of nausea and some serious hard candy sucking over a recurrence. More can 't hurt - really - & too little can be risky. I believe the docs on this list have had more success with initial aggressive treatment, which is probably why they do not recommend the lower dose. I have absolutely no studies to cite - this is ALL Anecdotal- which holds no weight for the docs or in a court room- but it is my perspective as a survivor and close observer. Buona fortuna a tutti. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.